The 20 Best Diffuse Large B-Cell Lymphoma (DLBCL) Doctors Near Me in California, US

Find the Top Diffuse Large B-Cell Lymphoma (DLBCL) Experts and Specialists

Last Updated: 04/28/2026

Save doctors for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Already have a doctor?
Find A Second Opinion

MediFind found 1160 doctor with experience in Diffuse Large B-Cell Lymphoma (DLBCL) near California, US. Of these, 881 are Experienced, 229 are Advanced, 45 are Distinguished and 5 are Elite.

Location
LocationClose
1,160 providers found
    Elite in Diffuse Large B-Cell Lymphoma (DLBCL)
    Elite in Diffuse Large B-Cell Lymphoma (DLBCL)

    Alex Herrera, M.D.

    1500 Duarte Rd, 
    Duarte, CA 
    Experience:
    17+ years
    Languages Spoken:
    English
    Offers Telehealth

    Alex Herrera is an Oncologist practicing medicine in Duarte, California. He has been practicing medicine for over 17 years. Dr. Herrera is rated as an Elite provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Herrera is board certified in American Board Of Internal Medicine, Hematology and American Board Of Internal Medicine, Oncology.

    Elite in Diffuse Large B-Cell Lymphoma (DLBCL)
    Elite in Diffuse Large B-Cell Lymphoma (DLBCL)

    Stanford University

    875 Blake Wilbur Dr, 
    Palo Alto, CA 
    Experience:
    44+ years
    Languages Spoken:
    English
    Offers Telehealth

    Ranjana Advani is an Oncologist practicing medicine in Palo Alto, California. She has been practicing medicine for over 44 years. Dr. Advani is rated as an Elite provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Tissue Biopsy.

    Elite in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology Oncology
    Elite in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology Oncology

    Cutaneous Lymphoma Clinic

    1701 Divisadero St., Fourth Floor, 
    San Francisco, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Dr. Wei Ai is a blood cancer specialist who cares for adults with conditions such as Hodgkin's lymphoma and non-Hodgkin's lymphoma, including cutaneous lymphomas, which primarily involve the skin. She also sees patients needing blood and bone marrow transplantation. In her research, Ai focuses on novel approaches to lymphoma treatment, especially targeted agents for T-cell lymphomas. Her studies often lead to clinical trials of new therapies that target cancer at the molecular level. Ai earned a doctoral degree in microbiology and immunology as well as her medical degree from Stanford University School of Medicine. She completed a residency in internal medicine at UCSF, followed by fellowship training in medical oncology at Stanford. Dr. Ai is rated as an Elite provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), T-Cell Lymphoma, Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Ai is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Ai is currently accepting new patients.

    Learn about our expert tiers
    Elite in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology
    Elite in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology

    Office

    2557 Mowry Ave Ste 34, 
    Fremont, CA 
    Languages Spoken:
    English

    Yasuhiro Oki is a Hematologist practicing medicine in Fremont, California. Dr. Oki is rated as an Elite provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

    Elite in Diffuse Large B-Cell Lymphoma (DLBCL)
    Elite in Diffuse Large B-Cell Lymphoma (DLBCL)

    Tycel Phillips, M.D.

    1500 Duarte Rd, 
    Duarte, CA 
    Languages Spoken:
    English
    Offers Telehealth

    Tycel Phillips is an Oncologist practicing medicine in Duarte, California. Dr. Phillips is rated as an Elite provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)

    Buhler Specialty Pavilion

    2800 L Street, Suite 260, 
    Sacramento, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Elias Kiwan is an Oncologist practicing medicine in Sacramento, California. Dr. Kiwan is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 77 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Large-Cell Immunoblastic Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Kiwan is board certified in Medical Oncology - Board Certified , Hematology - Board Certified , and Not ABMS Specialty. Dr. Kiwan is currently accepting new patients.

    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)

    Ravi Patel, M.D., Inc.

    6501 Truxtun Ave, 
    Bakersfield, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Dr. Ravi Patel is a board certified Medical Oncologist who has been practicing for more than 30 years. He completed his residency at the University of Illinois after obtaining a medical degree from Gujarat University Medical College in India. He went on to complete a fellowship in Hematology/ Oncology from Loyola University Stritch School of Medicine.From the early stages of his career, Dr. Patel was exposed to and focused on bone marrow transplantation along with a wide variety of oncology and hematology training.Dr. Patel founded Comprehensive Blood & Cancer Center in 1984, growing it from a 1,200 square foot office with one employee into the comprehensive, community focused, diagnostic, treatment, educational and research-based cancer center it is today with over 250 employees and a 120,000 square foot campus.While serving as managing director of the center, Dr. Patel continues to actively care for his patients and serve as principal investigator on the center's many clinical research studies. Dr. Patel is actively involved with the leading pharmaceutical manufacturers and academic research programs to assure that cancer patients in Kern County have access to the most cutting-edge medicines and treatments available anywhere in the world.Through choosing to work with the UCLA Jonsson Comprehensive Cancer Center TRIO-US Network, UCLA employees manage clinical trials alongside CBCC's own research staff. Several of the treatments tested at CBCC have proven to be highly successful and have gone on to receive approval from the Federal Government's Food and Drug Administration (FDA). These breakthrough treatments have changed the way many forms of cancer are now being managed around the world.As a result of his clinical research experience, Dr. Patel has authored several scientific papers in such respected journals as the Journal of Clinical Oncology and Clinical Lymphoma. He is sought after as a lecturer and consultant on clinical oncology issues and patient care. He serves as an Associate Clinical Professor of Medicine at UCLA and is actively involved with the Residency Program in Internal Medicine at the Kern County Medical Center. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 55 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Ampullary Cancer, Paget Disease of the Breast, and Diffuse Large B-Cell Lymphoma (DLBCL). Dr. Patel is board certified in Internal Medicine and Internal Medicine (Sub: Medical Oncology). Dr. Patel is currently accepting new patients.

    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Oncology | Hematology
    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Oncology | Hematology
    7320 Woodlake Avenue, Suite 330, 
    West Hills, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Omid Shaye is a Hematologist and an Oncologist practicing medicine in West Hills, California. Dr. Shaye is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Familial Colorectal Cancer, Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Shaye is currently accepting new patients.

    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology
    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology

    Premiere Oncology A Medical Corporation

    2020 Santa Monica Blvd Ste 600, 
    Santa Monica, CA 
    Languages Spoken:
    English
    Offers Telehealth

    Sven De Vos is a Hematologist practicing medicine in Santa Monica, California. Dr. De Vos is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology Oncology | Transplant Surgery
    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology Oncology | Transplant Surgery

    Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program

    400 Parnassus Ave., Fourth Floor, 
    San Francisco, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Dr. Charalambos (Babis) Andreadis specializes in bone marrow transplantation for adults and in treating Hodgkin's and non-Hodgkin's lymphoma, leukemia and multiple myeloma. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. His research, published widely in scientific journals, examines genetic and other factors that affect how patients respond to therapy, including degrees of drug toxicity. He also studies patient outcomes in these disorders. Andreadis earned his medical degree at Columbia University's Vagelos College of Physicians and Surgeons, and was elected to the Alpha Omega Alpha Honor Medical Society in 1998. He completed a residency at New York-Presbyterian Hospital and a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, where he joined the faculty in 2004. He also earned a master's degree in clinical epidemiology at the University of Pennsylvania, focusing on pharmacogenetics, the study of how genes impact an individual's response to medications. Dr. Andreadis is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Andreadis is board certified in American Board Of Internal Medicine/Hematology, Hematology and American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Andreadis is currently accepting new patients.

    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology | Oncology
    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology | Oncology

    Stephen J. Forman, M.D.

    1500 Duarte Rd, 
    Duarte, CA 
    Languages Spoken:
    English
    Offers Telehealth

    Stephen Forman is a Hematologist and an Oncologist practicing medicine in Duarte, California. Dr. Forman is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.

    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology Oncology
    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology Oncology

    Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program

    400 Parnassus Ave., Fourth Floor, 
    San Francisco, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Dr. Lawrence D. Kaplan, a hematologist-oncologist, directs UCSF's lymphoma program. He is an international leader in the treatment of lymphoma and HIV-associated lymphoma. In his research, Kaplan is particularly interested in developing new treatments for lymphoma and the HIV-related form of this cancer. Kaplan earned his medical degree at the David Geffen School of Medicine at UCLA. He completed a residency in medicine at Boston Medical Center and completed a fellowship in hematology and oncology at UCSF. He joined UCSF in 1985. Kaplan's professional activities include serving on the Lymphoma Working Group of the AIDS Malignancy Consortium, a clinical trials group supported by the National Cancer Institute (NCI). He formerly chaired the group's steering committee. He also serves on the lymphoma committee of Alliance for Clinical Trials in Oncology, a national research group sponsored by the NCI. Dr. Kaplan is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Kaplan is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Kaplan is currently accepting new patients.

    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)

    UCLA Health Bowyer Oncology Center

    200 UCLA Medical Plz Ste 120, 
    Los Angeles, CA 
    Languages Spoken:
    English
    Offers Telehealth

    Gary Schiller is an Oncologist practicing medicine in Los Angeles, California. Dr. Schiller is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology Oncology
    Distinguished in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology Oncology

    Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program

    400 Parnassus Ave., Fourth Floor, 
    San Francisco, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Dr. James Rubenstein is a hematologist-oncologist, or a specialist in blood disorders. He has particular expertise in treating patients with neurologic complications from cancer, including patients with non-Hodgkin's lymphoma involving the brain (called central nervous system lymphoma). He also specializes in patients with cancer that has spread to the brain from other parts of the body. In his research, Rubenstein investigates immunologic tools to improve tumor response to chemotherapy and radiation treatment, and to minimize toxicity from treatment. He is also interested in developing tumor biomarkers to diagnose brain tumors. Rubenstein earned his medical degree at Weill Cornell Medicine and completed a residency in internal medicine at Stanford Medicine. He earned a doctorate in molecular and cellular neurosciences at the Rockefeller University. He completed a fellowship in hematology and oncology at UCSF, which included training in neuro-oncology. Rubenstein has won research awards from the Leukemia & Lymphoma Society and the National Cancer Institute. He is a member of the American Society of Hematology, American Society of Clinical Oncology and American Association for Cancer Research. Dr. Rubenstein is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Primary Lymphoma of the Brain, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Vitrectomy, and Bone Marrow Aspiration. Dr. Rubenstein is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Rubenstein is currently accepting new patients.

    Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology | Oncology
    Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology | Oncology

    Genesiscare

    310 Hartnell Ave, 
    Redding, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Dr. Ali, as he is known to patients, is Board Certified in Medical Oncology and Internal Medicine and is fellowship-trained in Hematology and Oncology at the University of Louisville. He has published articles about genetic mutations and has presented his findings to physicians across the country. He is a respected member of the American Society of Clinical Oncology, the American Society of Hematology and the American College of Physicians. Named “Best Resident Teacher”at Good Samaritan Hospital in Cincinnati, he continues to use those skills to educate his patients about their disease with empathy and compassion. Dr. Abdolmohammadi is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 76 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Chronic B-Cell Leukemia (CBCL). Dr. Abdolmohammadi is board certified in Internal Medicine and Internal Medicine (Sub: Medical Oncology). Dr. Abdolmohammadi is currently accepting new patients.

    Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology | Oncology
    Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)
    Hematology | Oncology

    Oncology & Hematology - Mission Hope - Santa Maria, CA

    1325 E Church St, Ste 301, 
    Santa Maria, CA 
    Languages Spoken:
    English
    Accepting New Patients

    Board Certified in Medical Oncology, Hematology and Internal Medicine, Dr. Kennedy provides compassionate care for patients at Mission Hope Cancer Center, and works collaboratively with all departments to provide patients with all aspects of cancer care. Dr. Kennedy is able to offer patients the most advanced treatment with enrollment in cutting edge clinical research studies. She has years of experience in the treatment and diagnosis of all cancers and provides her patients with individualized care for the best possible outcomes.An educator at heart, Dr. Kennedy has a passion for teaching her patients about their disease and how their treatments work. Understanding a disease is empowering for the patient and can remove some of the fear associated with a cancer diagnosis.Dr. Kennedy received her medical degree from the University of Oklahoma. She completed her Internal Medicine residency at the University of California Davis, and Hematology-Oncology fellowship program at the University of Oklahoma Health Sciences Center-Stephenson Cancer Center.As an experienced principal investigator on numerous clinical trials for cancer therapies, Dr. Kennedy has published her findings in national medical journals, and puts her research knowledge into practice when treating patients. Dr. Kennedy is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Anal Cancer, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Kennedy is currently accepting new patients.

    Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)
    Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)

    ABSMC Comprehensive Cancer Center

    2001 Dwight Way, 
    Berkeley, CA 
    Languages Spoken:
    English
    Accepting New Patients

    Oleg Krijanovski is a Hematologist practicing medicine in Berkeley, California. Dr. Krijanovski is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 52 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Krijanovski is board certified in Hematology - Board Certified and Medical Oncology - Board Certified. Dr. Krijanovski is currently accepting new patients.

    Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)
    Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)

    8 Medical Plaza Care Center

    8 Medical Plaza Drive, Suite 300, 
    Roseville, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Sivakumar Reddy is a Hematologist practicing medicine in Roseville, California. Dr. Reddy is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 75 other conditions, according to our data. His clinical expertise encompasses Gastrointestinal Stromal Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Reddy is board certified in Hematology Medical Oncology. Dr. Reddy is currently accepting new patients.

    Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)
    Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)

    Cancer Center Burlingame

    225 California Drive, 
    Burlingame, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Dr. Bradley Ekstrand is a genitourinary oncologist who has particular interest and expertise in treating patients with lymphoma and genitourinary cancers. His background in the molecular biology of cancer gives him a unique perspective, combining a scientist's view of disease with a doctor's expertise, to bring the best care to patients with cancer. Ekstrand earned his medical degree from Yale School of Medicine, where he also completed a doctorate in cancer biology. During his doctoral studies, he worked in the lab of acclaimed cancer genetics researcher Dr. Eric Fearon, where he focused on tumor suppressor genes. He completed a residency in internal medicine at Mount Sinai Medical Center and a fellowship in medical oncology at Stanford University School of Medicine. During his fellowship, he worked extensively in lymphoma with Drs. Sandra Horning and Gilbert Chu. Ekstrand is a member of the American Society of Clinical Oncology and Association of Northern California Oncologists, where he serves as vice president. Through his work with these organizations, he advocates for high-quality cancer care for all patients. A native of Boulder, Colorado, Ekstrand enjoys outdoor recreation, particularly alpine skiing, swimming and long-distance running. Outside of work, he devotes most of his time to family activities with his wife and three children. An avid sports fan, he follows Stanford athletics, European soccer leagues and the Denver Broncos. Dr. Ekstrand is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Familial Prostate Cancer, Small Lymphocytic Lymphoma (SLL), and Large-Cell Immunoblastic Lymphoma. Dr. Ekstrand is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Ekstrand is currently accepting new patients.

    Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)
    Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)

    8 Medical Plaza Care Center

    8 Medical Plaza Drive, Suite 300, 
    Roseville, CA 
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Dron Gauchan is an Oncologist practicing medicine in Roseville, California. Dr. Gauchan is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 53 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Large-Cell Immunoblastic Lymphoma, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Neuroendocrine Tumor. Dr. Gauchan is board certified in Medical Oncology Hematology. Dr. Gauchan is currently accepting new patients.

    Showing 1-20 of 1,160

    Last Updated: 04/28/2026

    What is the definition of Diffuse Large B-Cell Lymphoma (DLBCL)?

    Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma and is an aggressive blood cancer that originates in the lymphatic system and affects B-lymphocytes, which is a type of white blood cell that helps to fight infection. Diffuse large B-cell lymphoma and can occur in one area of the body or throughout the body, and mainly occurs in individuals over the age of 60.  Diffuse large B-cell lymphoma is categorized by the following subtypes: T-cell/histiocyte-rich B-cell lymphoma – This subtype of diffuse large B-cell lymphoma has some scattered large and atypical B cells mixed with many normal T cells and histocytes (immune system cells). Primary diffuse large B-cell lymphoma of the central nervous system – This subtype of diffuse large B-cell lymphoma originates in either the brain or eye and can be a secondary development. Primary cutaneous diffuse large B-cell lymphoma, leg type – This subtype of diffuse large B-cell lymphoma is composed of large transformed B cells that create red or bluish-red tumors and can also involve the arms, trunk, buttocks, legs, or other areas. Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma of the elderly – This subtype of diffuse large B-cell lymphoma mainly occurs in patients over the age of 50 who test positive for the Epstein-Barr virus. Diffuse large B-cell lymphoma not otherwise specified (NOS) – This subtype of diffuse large B-cell lymphoma is for any that does not fall into one of the above classifications and represents 25-30% of diffuse large B-cell lymphoma in western countries. In addition to subtypes, diffuse large B-cell lymphoma is classified into the following stages: Stage I – The diffuse large B-cell lymphoma appears in one lymph node area or a cluster of nearby lymph nodes. Stage II – The diffuse large B-cell lymphoma appears in two lymph node area or has spread (metastasized) to one organ and nearby lymph nodes but is limited to an area of the body above or below the diaphragm.  Stage III – The diffuse large B-cell lymphoma appears in lymph nodes both above and below the diaphragm and may also appear in the spleen. Stage IV – This advanced stage diffuse large B-cell lymphoma appears in several areas of one or more organs and tissues and may also affect the liver, lungs, or bones. Diffuse large B-cell lymphoma is further classified by A or B to denote whether the patient is experiencing any significant symptoms (A), or if the patient has significant symptoms, such as unexplained weight loss, persistent fever, or severe night sweats (B).

    When should I see a Diffuse Large B-Cell Lymphoma (DLBCL) doctor in California, US?

    There are various reasons why you may want to see a specialist, such as: 

    • Your primary care provider recommends it. 
    • Your condition requires expert knowledge and specialized care. 
    • Your symptoms persist or worsen despite treatment. 
    • You need specialized testing or procedures. 
    • You want a second opinion.  

    What should I consider when choosing a Diffuse Large B-Cell Lymphoma (DLBCL) doctor in California, US?

    It’s important to see a provider with expertise in your specific condition. Each provider profile in MediFind’s doctor database includes information on which conditions they treat, years of experience, research contributions, languages spoken, insurance plans accepted, and more.  

    How does MediFind rank Diffuse Large B-Cell Lymphoma (DLBCL) doctors in California, US?

    MediFind’s rankings are based on a variety of data sources, such as the number of articles a doctor has published in medical journals, participation in clinical trials and industry conferences, as well as the number of patients that provider sees for a given condition. Note that MediFind’s provider database is not based on user reviews, and providers do not pay to be included in the database. 

    What types of insurance are accepted by Diffuse Large B-Cell Lymphoma (DLBCL) doctors in California, US?

    Most profiles in MediFind’s doctor database include a list of insurance plans accepted by that provider. However, it’s a good idea to contact the provider’s office to make sure they still accept your insurance, then doublecheck by contacting your insurance plan to confirm they’re in network. 

    How can I book an appointment online with a Diffuse Large B-Cell Lymphoma (DLBCL) doctor in California, US?

    MediFind offers direct scheduling for certain providers using the “Request Appointment” button on that provider’s profile. If the schedule option is not available for a provider, tap the red “Show Phone Number” button on their profile to get their contact information. If you prefer to find providers who offer online scheduling, select “Schedules online” under the “Availability” category of the filter feature on the left side of the Diffuse Large B-Cell Lymphoma (DLBCL) doctor search results page. 

    Why is it important to get a second opinion from a different Diffuse Large B-Cell Lymphoma (DLBCL) doctor?

    Second opinions are an opportunity to confirm a diagnosis and its root cause, learn about alternative treatment options, or simply gain peace of mind. Many people, especially those with serious diagnoses, get second opinions so they can understand all their options and make informed decisions, so don’t hesitate to get one if you have any doubts or need more information or clarification regarding your care. Note that some insurance plans require second opinions, while others don’t cover second opinions, so be sure to confirm with your insurance provider first.   

    How can I prepare for my appointment with a Diffuse Large B-Cell Lymphoma (DLBCL) doctor in California, US?

    Prepare for your appointment by gathering the following items: 

    • Copies of medical records (dating back at least one year) 
    • Your medical history, including illnesses, medical conditions, surgeries, and other doctors you see 
    • Family history of disease 
    • List of current prescription drugs, over-the-counter medicines, vitamins, and herbal remedies or supplements including names and doses 
    • Allergies to medications, food, latex, insects, etc.  
    • List of questions and concerns 
    • Your insurance card 

    You might also contact the provider’s office to see if they offer transportation or childcare services or if you’re allowed to bring a loved one for support or to take notes during your visit. 

    What questions should I ask my Diffuse Large B-Cell Lymphoma (DLBCL) doctor?

    Here are some sample questions: 

    • Can you explain in simple terms what this condition is and how it’s treated? 
    • What symptoms or side effects should I watch for? 
    • What tests will be involved, and when can I expect results? 
    • Are there other specialists I need to see? 
    • What’s the best way to reach you if I have follow-up questions? 

    How can I learn about the latest clinical trials and research advances my Diffuse Large B-Cell Lymphoma (DLBCL) doctor may know about?

    MediFind’s Clinical Trials tool asks you a series of questions to help you narrow down your search by health condition, age, gender, location, how far you’re willing to travel, and more. Each question you answer filters down the number of trials until you find the ones that are most relevant to you. 

    MediFind’s Latest Advances tool features summaries of recent articles published in medical journals. We use cutting-edge technology to scour medical publication databases for the latest research advancements on any given condition, then we simplify this information in a way that’s useful and easy to understand. 

    Can I filter my search to show male or female Diffuse Large B-Cell Lymphoma (DLBCL) doctors in California, US?

    Look for the filter feature on the left side of the Diffuse Large B-Cell Lymphoma (DLBCL) doctor search results page. Select “Female” or “Male” under the “Gender” category to search for female or male providers exclusively. If the “Any” option is selected, it will pull results for both male and female providers. 

    Can I filter my search to find a Diffuse Large B-Cell Lymphoma (DLBCL) doctor that offers video calls?

    Look for the filter feature on the left-side of the Diffuse Large B-Cell Lymphoma (DLBCL) doctor search results page. Select “Offers telehealth visits” under the Availability category to search for providers who offer virtual appointments (video calls). 

    Reviewed on: 11/11/24  

    By: MediFind Medical Staff 

    Read more about our Content Policy